TVGNW
Tevogen Bio Holdings Inc.NASDAQ
Key Statistics
Market Cap
—
P/E Ratio
—
EPS
—
Beta
0.22
52W High
$0.08
52W Low
$0.03
50-Day MA
$0.00
200-Day MA
$0.00
Dividend Yield
—
Profit Margin
0.00%
Forward P/E
—
PEG Ratio
—
About Tevogen Bio Holdings Inc.
Tevogen Bio Holdings Inc. is a clinical-stage biotechnology company that develops off-the-shelf precision T cell therapeutics in virology, oncology, and neurology. The company is headquartered in Warren, New Jersey.
Fundamentals
| Revenue (TTM) | 0 |
| Gross Profit (TTM) | 0 |
| EBITDA | $-21.00M |
| Operating Margin | 0.00% |
| Return on Equity | 0.00% |
| Return on Assets | -294.40% |
| Revenue/Share (TTM) | $0.00 |
| Book Value | $-4.47 |
| Price-to-Book | — |
| Price-to-Sales (TTM) | — |
| EV/Revenue | - |
| EV/EBITDA | — |
| Quarterly Earnings Growth (YoY) | 0.00% |
| Quarterly Revenue Growth (YoY) | 0.00% |
| Shares Outstanding | 0 |
| Float | $1.07M |
| % Insiders | 0.00% |
| % Institutions | 0.00% |
Historical Volatility
HV 10-Day
22.60%
HV 20-Day
121.57%
HV 30-Day
103.82%
HV 60-Day
91.03%
HV Rank
55.2%
Volatility is currently contracting
Turn research into an automated options-selling system
Tiblio connects your broker and runs your put-and-call-writing strategy for you — on TVGNW and any ticker you trade — then tracks every position and per-strategy win rate.
Data last updated: 7/29/2026